Scylla paramamosain antibacterial peptide Scyovacin19-30 and application thereof

The invention discloses a scylla paramamosain antibacterial peptide Scyovacin19-30 and application thereof, the molecular formula of the scylla paramamosain antibacterial peptide Scyovacin19-30 is C58H102N26O13S1, the amino acid sequence of the scylla paramamosain antibacterial peptide Scyovacin19-30 is shown as SEQ ID NO.01, and the C terminal of the scylla paramamosain antibacterial peptide Scyovacin19-30 is The antibacterial peptide disclosed by the invention is good in water solubility, high in antibacterial activity, wide in antibacterial spectrum, safe and wide in application prospect; the compound has good antibacterial activity on clinical pathogenic bacteria, main pathogenic fungi and aquatic pathogenic bacteria, and has no cytotoxicity on HaCaT and Raw264.7 cells..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 24. Nov. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

WANG KEJIAN [VerfasserIn]
ZHOU YING [VerfasserIn]
CHEN FANGYI [VerfasserIn]
PENG HUI [VerfasserIn]
HAO HUA [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A23K: Feeding-stuffs specially adapted for animals; metho (...)
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07K: Peptides (peptides containing β-lactam rings c07d; (...)
che
tec

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-11-24, Last update posted on www.tib.eu: 2024-02-05, Last updated: 2024-02-09

Patentnummer:

CN117106025

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA01918381X